We recently published a list of Jim Cramer Discussed These 12 Stocks & Elon Musk Vs Sam Altman. In this article, we are going ...
U.S. markets were rebounding at midday from yesterday's big tech selloff caused by advances in artificial intelligence by a ...
Rodman & Renshaw initiated coverage on PolyPid Ltd. (NASDAQ:PYPD), a late-stage biopharmaceutical company, with a Buy rating and a price target of $13.00. PolyPid specializes in the controlled and ...